# HIF-1α at the intersection of hypoxia, ferroptosis-associated stress, and cell death crosstalk in osteomyelitis

## TL;DR

This review explores how HIF-1α regulates cell death pathways like ferroptosis in the hypoxic environment of osteomyelitis, offering new therapeutic insights.

## Contribution

The paper highlights the novel role of HIF-1α in ferroptosis and its crosstalk with other cell death mechanisms in osteomyelitis.

## Key findings

- HIF-1α is significantly upregulated in the hypoxic microenvironment of osteomyelitis.
- HIF-1α regulates multiple forms of regulated cell death, including ferroptosis, which influences bone destruction.
- Targeting the HIF-1α-RCD axis presents potential therapeutic strategies for osteomyelitis.

## Abstract

Osteomyelitis is a severe inflammatory disease of bone tissue primarily caused by bacterial infections, most commonly Staphylococcus aureus. Its complex pathophysiology creates a unique hypoxic and inflamed microenvironment, which leads to the significant upregulation of the key transcriptional regulator, hypoxia-inducible factor-1α (HIF-1α). HIF-1α plays a pivotal role in disease progression, partly by orchestrating various forms of regulated cell death (RCD). The dysregulation of these RCD pathways, including apoptosis, pyroptosis, and particularly the emerging role of ferroptosis, is critically involved in shaping the fate of bone and immune cells, influencing the inflammatory response, and ultimately driving bone destruction. This review aims to comprehensively explore the regulatory mechanisms of HIF-1α on these RCD modalities, especially ferroptosis, and the intricate crosstalk among them. Moreover, we highlight emerging therapeutic strategies targeting the HIF-1α-RCD axis, offering novel insights into the pathogenesis and potential treatment avenues for this refractory orthopedic inflammatory condition.